CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-01-15 | HENOS MICHAEL A Director | Conversion · Series A-1 Preferred Stock | −39,413 | 0 | ||
| 2014-01-15 | HENOS MICHAEL A Director | Conversion · Series A-1 Preferred Stock | −1,114,690 | 0 | ||
| 2014-01-15 | Gust William M. Director | Conversion | +339,686 | 409,947 | ||
| 2014-01-15 | Gust William M. Director | Conversion · Series A-1 Preferred Stock | −1,121,646 | 0 | ||
| 2014-01-15 | BARRIS PETER J 10% owner | Conversion | +3,407,283 | 3,994,258 | ||
| 2014-01-15 | BARRIS PETER J 10% owner | Purchase | +487,500 | $8.00 | $3.9M | 4,481,758 |
| 2014-01-15 | BARRIS PETER J 10% owner | Conversion | +3,580,877 | 3,580,877 | ||
| 2014-01-15 | BARRIS PETER J 10% owner | Purchase | +512,500 | $8.00 | $4.1M | 4,093,377 |
| 2014-01-15 | BARRIS PETER J 10% owner | Conversion · Series A-1 Preferred Stock | −11,250,850 | 0 | ||
| 2014-01-15 | BARRIS PETER J 10% owner | Conversion · Series A-1 Preferred Stock | −11,824,058 | 0 | ||
| 2014-01-15 | SANDELL SCOTT D 10% owner | Conversion | +3,407,283 | 3,994,258 | ||
| 2014-01-15 | SANDELL SCOTT D 10% owner | Purchase | +487,500 | $8.00 | $3.9M | 4,481,758 |
| 2014-01-15 | SANDELL SCOTT D 10% owner | Conversion | +3,580,877 | 3,580,877 | ||
| 2014-01-15 | SANDELL SCOTT D 10% owner | Purchase | +512,500 | $8.00 | $4.1M | 4,093,377 |
| 2014-01-15 | SANDELL SCOTT D 10% owner | Conversion · Series A-1 Preferred Stock | −11,250,850 | 0 | ||
| 2014-01-15 | SANDELL SCOTT D 10% owner | Conversion · Series A-1 Preferred Stock | −11,824,058 | 0 | ||
| 2014-01-15 | BARRETT M JAMES Director | Conversion | +3,407,283 | 3,994,258 | ||
| 2014-01-15 | BARRETT M JAMES Director | Purchase | +487,500 | $8.00 | $3.9M | 4,481,758 |
| 2014-01-15 | BARRETT M JAMES Director | Conversion | +3,580,877 | 3,580,877 | ||
| 2014-01-15 | BARRETT M JAMES Director | Purchase | +512,500 | $8.00 | $4.1M | 4,093,377 |
Page 19 of 20 · 397 trades